MACVAT simplifies analysis of MA prescription drug (MA-PD) plans by turning benefit, premium, and enrollment data into usable insights. Whether evaluating plan designs, understanding market shifts, or tracking competitor value, MACVAT enables teams to focus on strategy, rather than the time-consuming task of gathering and interpreting Medicare Advantage plan benefit package data. As evidence, MACVAT is used by MAOs representing more than 92% of Medicare Advantage and Prescription Drug Plan enrollment. The platform supports strategic and operational decision-making across clinical, actuarial, and executive teams. By compiling four years of Medicare Advantage (MA) data, including our industry gold-standard value added metric, the MACVAT provides a clear view of how the market — and individual organizations — have evolved and shifted their strategies over time.